The study indicated the long-term effectiveness and safety of InterStim in patients with fecal incontinence of more than twice per week.
At three years, 86 percent of subjects had at least a 50 percent reduction in incontinent episodes and 40 percent had perfect continence.
Read the Diseases of the Colon & Rectum report on InterStim Therapy for incontinence.
Related Articles on Incontinence:
First Artificial Sphincter Could Treat Fecal, Urinary Incontinence
FDA Approves Solesta to Treat Life-Altering Fecal Incontinence
FDA Gastroenterology and Urology Device Panel Approves Fecal Incontinence Product
